[1]Patent:WO2005/23783,2005,A1,.Locationinpatent:Page/Pagecolumn18
[2]Patent:WO2004/24703,2004,A1,.Locationinpatent:Page10
[3]OrganicProcessResearchandDevelopment,2007,vol.11,#5,p.813-816
[4]Patent:CN105503749,2016,A,.Locationinpatent:Paragraph0053;0054;0055
[5]Patent:CN107586279,2018,A,.Locationinpatent:Paragraph0008;0018
[6]Patent:CN108503597,2018,A,.Locationinpatent:Paragraph0026;0034-0036
[7]Molecules,2017,vol.22,#10,
[8]BioorganicandMedicinalChemistryLetters,2006,vol.16,#15,p.4102-4106
[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,#15,p.4102-4106
[2]Patent:CN107586279,2018,A,.Locationinpatent:Paragraph0008;0017
[3]Patent:CN105503749,2016,A,.Locationinpatent:Paragraph0051;0052
[4]Molecules,2017,vol.22,#10,
[5]Heterocycles,2007,vol.71,#1,p.39-48
[6]Patent:WO2005/23783,2005,A1,.Locationinpatent:Page/Pagecolumn17-18
[7]Patent:WO2004/24703,2004,A1,.Locationinpatent:Page13-14
[1]Patent:CN108503597,2018,A,.Locationinpatent:Paragraph0026;0030-0031
[1]Patent:WO2005/70909,2005,A1,.Locationinpatent:Page/Pagecolumn25-26
[1]Heterocycles,2007,vol.71,#1,p.39-48
[2]BioorganicandMedicinalChemistryLetters,2006,vol.16,#15,p.4102-4106
[3]Molecules,2017,vol.22,#10,
[4]Patent:CN107586279,2018,A,
[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.4102-4106
[2]Patent:CN107586279,2018,A.Locationinpatent:Paragraph0008;0017
[3]Patent:CN105503749,2016,A.Locationinpatent:Paragraph0051;0052
[4]Molecules,2017,vol.22
[5]Patent:CN109503498,2019,A.Locationinpatent:Paragraph0005;0017-0019
[6]Heterocycles,2007,vol.71,p.39-48
[7]Patent:WO2005/23783,2005,A1.Locationinpatent:Page/Pagecolumn17-18
[8]Patent:WO2004/24703,2004,A1.Locationinpatent:Page13-14
[9]Patent:CN109627222,2019,A.Locationinpatent:Paragraph0027;0028;0029
[1]Patent:WO2005/23783,2005,A1.Locationinpatent:Page/Pagecolumn18
[2]Patent:WO2004/24703,2004,A1.Locationinpatent:Page10
[3]OrganicProcessResearchandDevelopment,2007,vol.11,p.813-816
[4]Patent:CN105503749,2016,A.Locationinpatent:Paragraph0053;0054;0055
[5]Patent:CN107586279,2018,A.Locationinpatent:Paragraph0008;0018
[6]Patent:CN108503597,2018,A.Locationinpatent:Paragraph0026;0034-0036
[7]Patent:CN109503498,2019,A.Locationinpatent:Paragraph0020-0021
[8]Molecules,2017,vol.22
[9]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.4102-4106
[1]Heterocycles,2007,vol.71,p.39-48
[1]Heterocycles,2007,vol.71,p.39-48
[2]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.4102-4106
[3]Patent:CN105503749,2016,A
[1]Heterocycles,2007,vol.71,p.39-48
[2]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.4102-4106
[3]OrganicProcessResearchandDevelopment,2007,vol.11,p.813-816
[4]Patent:CN105503749,2016,A
[5]Patent:CN104072426,2017,B
[6]Patent:CN108503597,2018,A
Title: Wakeling AE, et al. ZD1839: an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res. 2002 Oct 15;62(20):5749-54.